Biomarker-driven clinical trials: promises and pitfalls

Bookmark and Share
Published: 29 Oct 2020
Views: 270
Dr Renzo Canetta - Independent consultant

Dr Renzo Canetta speaks to ecancer about biomarker-driven clinical trials: promises and pitfalls, a topic that was presented at this year's virtual IBCD 2020.

He first explains some of the benefits of biomarker driven research, after which he moves on to explain the downside of this research.

Dr Canetta then highlights some of the challenges associated with this type of research and gives his opinion about what the future of biomarker driven clinical trials looks like.